Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study

SPRING Investigators, Marcus Maurer, William R. Lumry, H. Henry Li, Emel Aygören-Pürsün, Paula J. Busse, Joshua Jacobs, Christina Nurse, Mariam A. Ahmed, Maureen Watt, Ming Yu, W. H. Yang, E. Aygören-Pürsün, I. Martinez-Saguer, M. Maurer, H. Farkas, M. Perosa, J. Bernstein, P. Busse, J. S. JacobsH. H. Li, W. R. Lumry, S. M. Rehman, R. Tachdjian, H. J. Wedner, M. E. Weinstein

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology